ReShape Lifesciences Inc Financial Flexibility Index
ReShape Lifesciences Inc financial flexibility index. ReShape Lifesciences Inc (RSLS) has a Financial Flexibility Index of -1.40x as of June 2025. Free cash flow of $-4.49 Million (operating CF $-4.49 Million minus capex $0.00) represents -1% of total liabilities ($3.20 Million).
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of ReShape Lifesciences Inc (2005–2024)
Financial flexibility index of ReShape Lifesciences Inc from 2005 to 2024. Historical Financial Flexibility Index trend for ReShape Lifesciences Inc across 20 annual periods. Check ReShape Lifesciences Inc (RSLS) cash earnings ratio to evaluate the quality of earnings relative to operating cash generation.
ReShape Lifesciences Inc Financial Flexibility Index by Year (2005–2024)
ReShape Lifesciences Inc financial flexibility index by year from 2005 to 2024. Year-by-year free cash flow to debt coverage for ReShape Lifesciences Inc. For the full cash flow conversion analysis, see ReShape Lifesciences Inc cash flow conversion.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -0.88x | $-4.43 Million | $-4.43 Million | $5.05 Million | ▲ +79.3% |
| 2023 | -4.23x | $-16.92 Million | $-16.96 Million | $4.00 Million | ▼ -45.3% |
| 2022 | -2.91x | $-21.77 Million | $-21.90 Million | $7.48 Million | ▼ -58.6% |
| 2021 | -1.84x | $-15.02 Million | $-15.38 Million | $8.19 Million | ▼ -407.7% |
| 2020 | -0.36x | $-8.16 Million | $-8.55 Million | $22.57 Million | ▲ +60.4% |
| 2019 | -0.91x | $-14.19 Million | $-14.20 Million | $15.55 Million | ▲ +51.4% |
| 2018 | -1.88x | $-27.44 Million | $-27.49 Million | $14.61 Million | ▲ +5.2% |
| 2017 | -1.98x | $-24.45 Million | $-24.59 Million | $12.34 Million | ▲ +60.6% |
| 2016 | -5.03x | $-20.64 Million | $-20.66 Million | $4.10 Million | ▼ -76.5% |
| 2015 | -2.85x | $-22.57 Million | $-22.61 Million | $7.91 Million | ▼ -14.1% |
| 2014 | -2.50x | $-19.29 Million | $-19.38 Million | $7.72 Million | ▼ -62.5% |
| 2013 | -1.54x | $-18.01 Million | $-18.43 Million | $11.71 Million | ▲ +2.4% |
| 2012 | -1.58x | $-22.40 Million | $-22.48 Million | $14.22 Million | ▲ +0.4% |
| 2011 | -1.58x | $-19.68 Million | $-19.94 Million | $12.44 Million | ▼ -4.0% |
| 2010 | -1.52x | $-13.66 Million | $-13.66 Million | $8.98 Million | ▲ +33.9% |
| 2009 | -2.30x | $-24.47 Million | $-24.66 Million | $10.63 Million | ▼ -16.2% |
| 2008 | -1.98x | $-33.42 Million | $-33.67 Million | $16.87 Million | ▼ -20.9% |
| 2007 | -1.64x | $-22.57 Million | $-23.37 Million | $13.77 Million | ▲ +21.3% |
| 2006 | -2.08x | $-15.59 Million | $-16.23 Million | $7.49 Million | ▼ -103.1% |
| 2005 | -1.03x | $-9.83 Million | $-10.28 Million | $9.59 Million | — |